Optibrium and Certara Collaborate
News Apr 21, 2015
Optibrium™ and Certara® have announced a collaboration to provide their mutual customers with an integrated solution linking Optibrium’s StarDrop™ with Certara’s D360™ platform. The combination of these two products enables researchers to combine the industry-leading self-service data access and analysis capabilities of D360, with StarDrop’s unique, interactive environment that guides compound selection and design decisions in drug discovery, helping project teams to identify high quality compounds more efficiently.
D360 provides scientific data integration, access, analysis, and visualisation capabilities for early discovery through to the preclinical and clinical phases of drug development. D360 solves both intra and inter-domain research challenges by integrating data from multiple source systems to provide both standard data views and data mining capabilities. In addition, D360 brings context and understanding to the data, enabling scientists to gain deeper insight and make better scientific decisions. Integration with Optibrium’s StarDrop suite enables researchers to seamlessly retrieve their compound data using D360 from within StarDrop’s intuitive environment for viewing and interacting with their data in the context of a discovery project. StarDrop provides a highly visual way to interpret data on compounds and their relationships, clearly highlighting the best chemistries and multi-parameter optimisation strategies for drug discovery. The combination of the two platforms further extends their capabilities to reduce the time and cost associated with identifying high quality compounds and new optimisation strategies.
Dr Matthew Segall, CEO of Optibrium, commented: “This latest collaboration demonstrates our commitment to delivering a seamless integration between StarDrop and our users’ data access infrastructure. We’ve responded to feedback from global pharma companies that requested integration between these two platforms be made available in the most user-friendly way. We are pleased at the ease with which this integration has been implemented.”
“D360 has established a clear position as the leading scientific informatics solution by leveraging Certara’s unparalleled domain expertise in biosimulation and scientific informatics”, said Dr David Lowis, Certara’s Director of Informatics Product Management. “We are excited to add Optibrium to the growing network of D360 partners. Working together we have enabled our clients to further optimise their work by leveraging D360’s open architecture to seamlessly connect StarDrop with the data mining and analytics capabilities provided by D360.”
The results of this collaboration are available to existing clients using D360 and StarDrop 6.0.
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Antibody Drug-Conjugate to Target Treatment-Resistant Childhood LeukemiaNews
Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.
Comments | 0 ADD COMMENT
International Conference on Nanomedicine and Nanotechnology
Aug 20 - Aug 21, 2018
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018